Seizure News and Research

Latest Seizure News and Research

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

The majority of epilepsy patients who have brain surgery to treat their disorder are satisfied with the results in reducing epilepsy-related seizures and improving their psychological and social well-being.

9 Dec 2013

Study demonstrates safety and efficacy of NeuroPace RNS System in adults with intractable seizures

Researchers present the findings from a 2-year multicenter randomized double blinded controlled clinical study and a 7 year long-term treatment study of the NeuroPace RNS System at the American Epilepsy Society's 67th Annual Meeting.

9 Dec 2013

Study: Uncontrolled epilepsy associated with higher healthcare utilization

Seizures in people with epilepsy are commonly treated with anti-epileptic drugs (AEDs) but 30-40 percent do not achieve adequate seizure control, predisposing them to severe health risks, impaired quality of life and higher healthcare costs.

9 Dec 2013

Underlying loss of awareness during partial seizures is same as deep sleep

Epilepsy patients with complex partial seizures have impaired consciousness during seizure episodes and typically have no memory of the event. However, the mechanisms of seizure unconsciousness are unclear.

9 Dec 2013

Researchers investigate effect of epilepsy surgery on patients lives

Resective surgery is an effective treatment for dug-resistant epilepsy. To investigate the effect of epilepsy surgery on patients lives, researchers from the Comprehensive Epilepsy Program at the Henry Ford Hospital in Detroit conducted a long-term retrospective follow up of surgical patients and correlated post-surgical psychosocial outcomes with seizure outcome and brain area surgically treated.

9 Dec 2013

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.

6 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Garden-Gateway believes chronic sufferers can cope with holiday stress

The holidays are a time of high stress for all of us. This is especially true for the many Californians who suffer from chronic illness or disease. It's well documented that stress can aggravate a wide range of chronic ailments, both physical and psychological, such as back pain, cancer, PTSD or immune system deficiency.

30 Nov 2013

Anti-epileptic drugs, bone loss and supplements

Antiepileptic drugs are medications used to prevent and control seizure disorders. These medications are also frequently used for other diagnoses other than seizures, however this current study concentrated on patients with a seizure disorder.

25 Nov 2013

UT Arlington assistant professor develops computational model to predict epileptic seizure

A UT Arlington assistant engineering professor has developed a computational model that can more accurately predict when an epileptic seizure will occur next based on the patient's personalized medical information.

22 Nov 2013

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.

21 Nov 2013

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Because of its participation in a pivotal trial, Henry Ford Hospital will be the first in Michigan to offer electric stimulation of the brain using a newly FDA-approved device for hard-to-treat epilepsy cases.

21 Nov 2013

Vaccinating kids against rotavirus may also reduce risk of seizures

A new study suggests an additional-and somewhat surprising-potential benefit of vaccinating children against rotavirus, a common cause of diarrhea and vomiting. Besides protecting kids from intestinal illness caused by rotavirus, immunization may also reduce the risk of related seizures, according to findings published in Clinical Infectious Diseases and available online.

21 Nov 2013

Watertree Health, Make-A-Wish Arizona partner to support children with life-threatening conditions

Nonprofit organizations should never have to decrease their services due to the economy. That is why Watertree Health, a leading provider of FREE prescription discount cards, is partnering with Make-A-Wish Arizona to provide financial support for the work they do for children with life-threatening medical conditions.

20 Nov 2013

Basic first aid tips for people with epilepsy

Ask Patricia Gibson and she can tell you numerous stories that convey the misconceptions associated with epilepsy. She will tell you about people who have been misdiagnosed and later arrested for their odd behavior following a seizure. She will tell you that she's known people with epilepsy who have been inadvertently hurt by would-be good Samaritans. Most importantly, she will tell you that there are ways to help.

18 Nov 2013

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

14 Nov 2013

Seizure News and Research

Latest Seizure News and Research

Majority of epilepsy surgery patients satisfied with results in improving psychological and social well-being

Study demonstrates safety and efficacy of NeuroPace RNS System in adults with intractable seizures

Study: Uncontrolled epilepsy associated with higher healthcare utilization

Underlying loss of awareness during partial seizures is same as deep sleep

Researchers investigate effect of epilepsy surgery on patients lives

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Garden-Gateway believes chronic sufferers can cope with holiday stress

Anti-epileptic drugs, bone loss and supplements

UT Arlington assistant professor develops computational model to predict epileptic seizure

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Vaccinating kids against rotavirus may also reduce risk of seizures

Watertree Health, Make-A-Wish Arizona partner to support children with life-threatening conditions

Basic first aid tips for people with epilepsy

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

Experts gather for first national conference focusing on the treatment of non-epileptic seizures

Aptiom receives FDA approval to treat seizures associated with epilepsy

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Seizure News and Research

Latest Seizure News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in